(firstQuint)Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects.

 Pediatric patients with partial onset epilepsy enrolled in a pharmacokinetic study of OXC XR were allowed to continue treatment with the investigational drug in this extension study.

 The primary interest was in assessing the safety of treatment with OXC XR over a period of months.

.

 Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects@highlight

Follow-on study to continue evaluation of the safety of OXC XR as adjunctive therapy in pediatric epilepsy